SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
Go back to SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK| SCYNEXIS (NASDAQ: SCYX) | Delayed: 4.48 +0.10 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.38 | 52 Week High | $7.29 | |||
| Open | $4.38 | 52 Week Low | $1.74 | |||
| Day High | $4.54 | P/E | N/A | |||
| Day Low | $4.31 | EPS | $0.00 | |||
| Volume | 47,801 | |||||
